Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¤½ÅºÐ¿­ÁõȯÀÚ¿Í ÀϹÝȯÀÚÀÇ º¹¿ë¾à¹° ìãò±¿¡ °üÇÑ ºñ±³¿¬±¸ A Comparative Study of Schizophrenic and Medical Inpatients as Informed Drug Consumers

ÀÌÈ­ÀÇ´ëÁö 1979³â 2±Ç 1È£ p.43 ~ 47
¿ìÇà¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
¿ìÇà¿ø (  ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ Àǰú´ëÇÐ ½Å°æÁ¤½Å°úÇб³½Ç

Abstract


Fifty schizophrenic inpatients receiving antipsychotic medications were evaluated as informed and or consenting drug consumers by means of structured interview, in comparison with a matched ¢¥group of medical inpatients receiving nonpsychotrpic drugs_ .
Medical patients were better informed about positive aspects of medication, such as relationship of drug treatment-to a specific diagnosis and not better informed. about.-positive aspects of medication, such as_ name _ and dose. _
Schizophrenic patients, however, were significantly better informed about side effects and risks.
Although both groups felt that their medication had helped them, 8016 of the medical patients but only 72% of the schizophrenic patients said they would take the medication if they had choice.
The fact that schizophrenic inpatients -readly shared their reluctance to take medication with an interviewer may offer an avenue for detection and intervention improve prospects for outpatient compliance.

Ű¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸